GREY:ATBPF - Post by User
Comment by
Pragmatiston Apr 23, 2021 12:26pm
164 Views
Post# 33055494
RE:RE:I'm still trying to figure out
RE:RE:I'm still trying to figure outStoxxhp wrote: I'm not entirely sure how someone can be so incredibly and naively uneducated.
For all you or we know they are speaking with pfizer and they were told they need to amalgamate in order to proceed with partnership.
Is it really that impossible to read between the lines to figure that out as a possibility?
Do you actually believe Dan is sitting there by himself making decisions? There are a whole host of people directing the decisions.
The ignorance and just complete lack of thought on this board is staggering.
Amalgamation would likely be necessary if Pfizer or another pharma is seeking more than a standard licensing deal.
Dan recently confirmed by email what he said during BioPub, that is, Antibe (and not Holdings) owns the IP associated with the new molecules activity.
This might explain in part why there is a need to unify the control/ownership of the IP at this time when previously the existing IH/ATE licensing arrangements sufficed.
It looks like both Antibe and Holdings has somthing to offer at the negotiating table. We will soon find out how much value is given to the new IP.